Related Experiment Video
Updated: Jun 10, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Novel tumor immunotherapy: Targeting dysfunctional antigen presenting cells
Shuang Wei1, Ilona Kryczek, Linhua Zou
1Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, LA 70112, USA.
Discovery Medicine
|August 14, 2010
Summary
Antigen-presenting cells (APCs) are crucial for immune responses but become dysfunctional in tumors. Depleting these tumor-associated APCs may offer a novel strategy for cancer immunotherapy.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Biology
Background:
- The immune and nervous systems share organizational and memory characteristics.
- Immune responses rely on cellular collaboration, unlike the centralized control of the nervous system.
- Antigen-presenting cells (APCs) are key orchestrators of adaptive immunity.
Purpose of the Study:
- To investigate the role and function of antigen-presenting cells (APCs) within the tumor microenvironment.
- To explore the potential of targeting tumor-associated APCs as a therapeutic strategy in cancer immunotherapy.
Main Methods:
- Comparative analysis of immune and nervous system organization.
- Identification and characterization of APC populations in tumor microenvironments.
- Assessment of APC function (antigen presentation, T cell stimulation/suppression) in vitro and in vivo.
Main Results:
- Tumor-associated APCs, including macrophages and dendritic cells, are frequently found in the tumor microenvironment.
- These APCs exhibit significant dysfunction, promoting T cell suppression and tumor angiogenesis rather than immune activation.
- Dysfunctional APCs in tumors hinder effective anti-tumor immune responses.
Conclusions:
- Antigen-presenting cells within the tumor microenvironment are often immunosuppressive.
- Targeting and depleting these dysfunctional APCs presents a promising novel therapeutic avenue for enhancing cancer immunotherapy efficacy.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...